Delivery Order SPE2DE24D0013-SPE2D626F48DJ
Award Date 2/6/26
Potential Completion Date 2/13/26
Potential Value $52K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain issued a $6,800 delivery order to Cepheid on February 5, 2026, under a parent Indefinite Delivery Contract for molecular diagnostic reagents and test kits. Place of performance is Sunnyvale, CA 94089. The order has a firm fixed-price structure with an ultimate completion date of February 12, 2026. The delivery covers diagnostic testing supplies supporting Cepheid's GeneXpert diagnostic platform, which provides molecular testing for infectious...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $26,627.40 delivery order (XPRSMVP-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a completion date of September 26, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the agency's procurement of diagnostic testing solutions from Cepheid, a company specializing in advanced molecular diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,270.50 firm fixed-price delivery order to Cepheid Inc. on November 20, 2025, for SARS-CoV-2+ 10S diagnostic test supplies. The delivery order, which has an ultimate completion date of December 5, 2025, was issued with no set-aside designation. Cepheid, headquartered in Sunnyvale, California, is a primary federal supplier of advanced molecular diagnostic systems and reagents, with established expertise in COVID-19 testing and...
- The Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $1,190.28 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 23, 2025, carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare...
- The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $1,597.30 by the Defense Logistics Agency Medical Supply Chain on January 5, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, designated 4570403902, carries no set-aside designation and represents procurement of diagnostic testing supplies, test kits, and reagents aligned with Cepheid's core competency in...
- On November 26, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,120 to Cepheid Inc., a molecular diagnostic systems manufacturer headquartered in Sunnyvale, California. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, calls for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus. The order is scheduled for completion by December 4, 2025, and carries no set-aside designation....
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The Defense Logistics Agency Medical Supply Chain awarded a $4,320 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, on February 3, 2026, with an ultimate completion date of February 10, 2026. This firm fixed-price delivery order, designated as a child contract with no set-aside designation, represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic solutions to the Defense Health Agency...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F48DJDelivery Order
The Defense Logistics Agency Medical Supply Chain issued a delivery order to Cepheid on February 6, 2026, with a ceiling value of $52,387.20 under an Indefinite Delivery Contract for molecular diagnostic testing supplies and reagents. Ultimate completion is February 13, 2026. Place of performance is Sunnyvale, CA 94089. The order is firm fixed price with no set-aside designation. Cepheid is a manufacturer of molecular diagnostic systems and reagents, headquartered in Sunnyvale, specializing in rapid diagnostic testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, MRSA, tuberculosis, and sexually transmitted infections through its GeneXpert diagnostic platform.
Generated 5/7/26, 10:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.4k | 2/5/26 |